Primary |
Hypertension |
40.6% |
Cardiac Failure Chronic |
17.9% |
Diabetes Mellitus |
5.1% |
Hyperlipidaemia |
4.6% |
Constipation |
3.7% |
Gastritis |
2.9% |
Atrial Fibrillation |
2.7% |
Angina Pectoris |
2.5% |
Insomnia |
2.5% |
Diabetes Mellitus Non-insulin-dependent |
2.4% |
Thrombosis Prophylaxis |
2.0% |
Hyperuricaemia |
1.7% |
Cerebral Infarction |
1.6% |
Rheumatoid Arthritis |
1.6% |
Asthma |
1.5% |
Gastric Ulcer |
1.4% |
Prophylaxis |
1.4% |
Type 2 Diabetes Mellitus |
1.3% |
Drug Use For Unknown Indication |
1.2% |
Reflux Oesophagitis |
1.2% |
|
Interstitial Lung Disease |
22.6% |
Rhabdomyolysis |
11.1% |
Cerebral Infarction |
6.7% |
Cerebral Haemorrhage |
6.0% |
Sudden Death |
6.0% |
Hypoglycaemia |
5.6% |
Cardiac Failure |
5.2% |
Oligohydramnios |
5.2% |
Renal Impairment |
4.4% |
Liver Disorder |
2.8% |
Myocardial Infarction |
2.8% |
Pancytopenia |
2.8% |
Pneumonia |
2.8% |
Ventricular Tachycardia |
2.8% |
Loss Of Consciousness |
2.4% |
Suicide Attempt |
2.4% |
Syncope |
2.4% |
Transient Ischaemic Attack |
2.4% |
Drug Eruption |
2.0% |
Hyperkalaemia |
2.0% |
|
Secondary |
Hypertension |
42.1% |
Drug Use For Unknown Indication |
9.5% |
Cardiac Failure |
5.1% |
Hyperlipidaemia |
4.9% |
Cardiac Failure Chronic |
4.8% |
Diabetes Mellitus |
4.7% |
Product Used For Unknown Indication |
3.1% |
Insomnia |
3.1% |
Rheumatoid Arthritis |
2.9% |
Hyperuricaemia |
2.7% |
Constipation |
2.0% |
Reflux Oesophagitis |
1.9% |
Thrombosis Prophylaxis |
1.9% |
Hypertriglyceridaemia |
1.7% |
Osteoporosis |
1.7% |
Gastric Ulcer |
1.7% |
Atrial Fibrillation |
1.6% |
Diabetes Mellitus Non-insulin-dependent |
1.6% |
Renal Transplant |
1.5% |
Gout |
1.5% |
|
Interstitial Lung Disease |
13.5% |
Shock |
8.8% |
Liver Disorder |
7.9% |
Rhabdomyolysis |
7.4% |
Renal Impairment |
6.0% |
Leukocytoclastic Vasculitis |
5.6% |
Pneumonia |
5.1% |
Nasopharyngitis |
4.2% |
Overdose |
4.2% |
Thrombocytopenia |
4.2% |
Ventricular Tachycardia |
4.2% |
Renal Failure |
3.7% |
Cardiac Failure |
3.3% |
Hyperkalaemia |
3.3% |
Pancytopenia |
3.3% |
Pyrexia |
3.3% |
Suicide Attempt |
3.3% |
Vomiting |
3.3% |
Blood Lactate Dehydrogenase Increased |
2.8% |
Hypoglycaemia |
2.8% |
|
Concomitant |
Hypertension |
31.7% |
Product Used For Unknown Indication |
9.8% |
Drug Use For Unknown Indication |
6.6% |
Rheumatoid Arthritis |
6.5% |
Prophylaxis |
6.1% |
Diabetes Mellitus |
4.8% |
Chronic Hepatitis C |
3.7% |
Constipation |
3.3% |
Insomnia |
3.1% |
Gastritis |
3.0% |
Hyperlipidaemia |
2.6% |
Metastatic Renal Cell Carcinoma |
2.5% |
Pain |
2.3% |
Type 2 Diabetes Mellitus |
2.2% |
Osteoporosis |
2.2% |
Cardiac Failure |
2.0% |
Hepatitis C |
2.0% |
Angina Pectoris |
1.9% |
Herpes Zoster |
1.9% |
Depression |
1.7% |
|
White Blood Cell Count Decreased |
10.3% |
Vomiting |
9.3% |
Pyrexia |
7.6% |
Renal Impairment |
6.9% |
Renal Failure Acute |
5.7% |
Pneumonia |
5.2% |
Hepatic Function Abnormal |
5.0% |
Interstitial Lung Disease |
4.8% |
Rhabdomyolysis |
4.5% |
White Blood Cell Count Increased |
4.4% |
Sepsis |
4.3% |
Rash |
4.0% |
Liver Disorder |
3.9% |
Death |
3.8% |
Platelet Count Decreased |
3.7% |
Renal Failure |
3.7% |
Thrombocytopenia |
3.6% |
Cerebral Infarction |
3.0% |
Loss Of Consciousness |
3.0% |
Stomatitis |
3.0% |
|
Interacting |
Hypertension |
45.1% |
Hiv Infection |
6.6% |
Blood Pressure Increased |
5.5% |
Blood Pressure Abnormal |
4.4% |
Chronic Myeloid Leukaemia |
4.4% |
Thyroid Cancer |
4.4% |
Pain |
3.3% |
Prophylaxis Against Gastrointestinal Ulcer |
3.3% |
Type 2 Diabetes Mellitus |
3.3% |
Coronary Artery Disease |
2.2% |
Dyslipidaemia |
2.2% |
Goitre |
2.2% |
Neoplasm Malignant |
2.2% |
Osteoporosis |
2.2% |
Prophylaxis |
2.2% |
Restless Legs Syndrome |
2.2% |
Arteritis Obliterans |
1.1% |
Cerebral Infarction |
1.1% |
Diabetes Mellitus |
1.1% |
Gastritis |
1.1% |
|
Shock |
19.0% |
Hypertensive Crisis |
14.3% |
Sick Sinus Syndrome |
14.3% |
Transaminases Increased |
14.3% |
Drug Interaction |
9.5% |
Hypertension |
9.5% |
Dizziness |
4.8% |
Hyperkalaemia |
4.8% |
Ventricular Tachycardia |
4.8% |
Vomiting |
4.8% |
|